Enable Injections has entered into a development agreement with Genentech. This partnership includes the potential for multiple molecule development programs including enFuse, under development by Enable to enable patient-administered subcutaneous delivery of high-volume therapeutics. Enable’s enFuse is an on-body drug delivery platform with a drug transfer system compatible with standard syringes or vial container formats. The wearable enFuse platform is being developed for subcutaneous ...